US 10975167
Method to reduce pulmonary arterial hypertension by administering inhibitors of nicotinamide phosphoribotransferase
granted A61KA61K2039/505A61K2039/545
Quick answer
US patent 10975167 (Method to reduce pulmonary arterial hypertension by administering inhibitors of nicotinamide phosphoribotransferase) held by Arizona Board of Regents on Behalf of the University of Arizona expires Mon Apr 08 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Arizona Board of Regents on Behalf of the University of Arizona
- Grant date
- Tue Apr 13 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 08 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61K, A61K2039/505, A61K2039/545, A61K31/403, A61K31/4045